KR101244609B1 - 트리펩티드 및 테트라펩티드 티오에테르 - Google Patents

트리펩티드 및 테트라펩티드 티오에테르 Download PDF

Info

Publication number
KR101244609B1
KR101244609B1 KR1020077018022A KR20077018022A KR101244609B1 KR 101244609 B1 KR101244609 B1 KR 101244609B1 KR 1020077018022 A KR1020077018022 A KR 1020077018022A KR 20077018022 A KR20077018022 A KR 20077018022A KR 101244609 B1 KR101244609 B1 KR 101244609B1
Authority
KR
South Korea
Prior art keywords
compound
substituted
unsubstituted
halo
glutamyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020077018022A
Other languages
English (en)
Korean (ko)
Other versions
KR20070104391A (ko
Inventor
나탈리아 아우레코에체아
앤드류 비 켈슨
로버트 더블유 맥사타
루이스 로빈슨
안소니 제이 산체스
니콜라스 엠 산티아고
스티븐 알 쇼우
레이나 제이 시몬
Original Assignee
텔리크 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 텔리크 인코포레이티드 filed Critical 텔리크 인코포레이티드
Publication of KR20070104391A publication Critical patent/KR20070104391A/ko
Application granted granted Critical
Publication of KR101244609B1 publication Critical patent/KR101244609B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020077018022A 2005-01-06 2006-01-04 트리펩티드 및 테트라펩티드 티오에테르 Expired - Fee Related KR101244609B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64193205P 2005-01-06 2005-01-06
US60/641,932 2005-01-06
PCT/US2006/000219 WO2006074249A1 (en) 2005-01-06 2006-01-04 Tripeptide and tetrapeptide thioethers

Publications (2)

Publication Number Publication Date
KR20070104391A KR20070104391A (ko) 2007-10-25
KR101244609B1 true KR101244609B1 (ko) 2013-03-25

Family

ID=36123437

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020077018022A Expired - Fee Related KR101244609B1 (ko) 2005-01-06 2006-01-04 트리펩티드 및 테트라펩티드 티오에테르
KR1020077012531A Ceased KR20070091611A (ko) 2005-01-06 2006-01-05 트리펩티드 및 테트라펩티드 술폰

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020077012531A Ceased KR20070091611A (ko) 2005-01-06 2006-01-05 트리펩티드 및 테트라펩티드 술폰

Country Status (24)

Country Link
US (2) US7129215B2 (enExample)
EP (2) EP1833978B1 (enExample)
JP (2) JP4903716B2 (enExample)
KR (2) KR101244609B1 (enExample)
CN (2) CN101090977B (enExample)
AR (2) AR051890A1 (enExample)
AT (2) ATE410520T1 (enExample)
AU (2) AU2006204022B2 (enExample)
BR (2) BRPI0606520A2 (enExample)
CA (2) CA2587284C (enExample)
DE (2) DE602006003064D1 (enExample)
DK (2) DK1833978T3 (enExample)
EA (2) EA200701398A1 (enExample)
ES (2) ES2314890T3 (enExample)
HR (2) HRP20090128T3 (enExample)
IL (2) IL182836A (enExample)
MX (2) MX2007008255A (enExample)
NZ (2) NZ555362A (enExample)
PL (2) PL1833978T3 (enExample)
PT (2) PT1833978E (enExample)
SI (2) SI1833978T1 (enExample)
TW (2) TWI317739B (enExample)
WO (2) WO2006074249A1 (enExample)
ZA (2) ZA200704487B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198247B2 (en) * 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
WO2006074249A1 (en) * 2005-01-06 2006-07-13 Telik, Inc. Tripeptide and tetrapeptide thioethers
US20070154963A1 (en) * 2005-12-30 2007-07-05 Danying Cai Method to determine whether a compound is a cellular GSTpi inhibitor
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
AU2006350707A1 (en) 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
KR20210103586A (ko) 2007-06-04 2021-08-23 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
CN107320732B (zh) 2008-12-04 2021-09-07 于崇曦 高穿透性组合物及其应用
DE102008060888A1 (de) 2008-12-09 2010-06-10 Evonik Stockhausen Gmbh Verfahren zur Herstellung von Acrolein umfassend die Aufarbeitung einer Rohglycerin-Phase
CN109232716A (zh) 2009-05-08 2019-01-18 上海泰飞尔生化技术有限公司 多肽和多肽相关化合物的高穿透力前药组合物
WO2011156045A2 (en) * 2010-06-07 2011-12-15 Telik, Inc. Tablet formulation of ezatiostat
CN102939300A (zh) 2010-06-07 2013-02-20 泰立克公司 无溶剂化晶体依泽替米贝盐酸盐d型的制备
US20130035389A1 (en) * 2011-08-05 2013-02-07 Telik, Inc. Methods for treating myelodysplastic syndrome with ezatiostat
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CN106146616A (zh) * 2015-04-03 2016-11-23 浙江海正药业股份有限公司 环肽类化合物及其制备和用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008563A1 (en) 1993-09-24 1995-03-30 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
WO1998009986A1 (en) 1996-09-02 1998-03-12 The Manchester Metropolitan University S-blocked glutathiones

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) * 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5556942A (en) 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5767086A (en) * 1992-04-03 1998-06-16 Terrapin Technologies, Inc. Bone marrow stimulation by certain glutathione analogs
US5955432A (en) * 1992-04-03 1999-09-21 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
CA2105492C (en) 1993-09-03 2000-02-01 Lawrence M. Kauvar Glutathione analogs and paralog panels comprising glutathione mimics
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
ATE280582T1 (de) 1995-06-07 2004-11-15 Telik Inc Stoffwechseleffekt von bestimmten glutation analogen
EP1072608B1 (en) * 1998-04-16 2005-06-15 Teijin Limited Glutathione derivatives and dosage forms thereof
EP1143992B1 (en) 1999-01-27 2005-01-12 Telik, Inc. Therapeutic compositions containing glutathione analogs
US7029695B2 (en) * 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
WO2006074249A1 (en) 2005-01-06 2006-07-13 Telik, Inc. Tripeptide and tetrapeptide thioethers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008563A1 (en) 1993-09-24 1995-03-30 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
WO1998009986A1 (en) 1996-09-02 1998-03-12 The Manchester Metropolitan University S-blocked glutathiones

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Journal of Medicinal Chemistry, Vol.14, pp.402-404 (1971.) *
Pesticide Biochemistry and Physiology, Vol.37, pp.121-129 (1990.) *

Also Published As

Publication number Publication date
ATE410440T1 (de) 2008-10-15
CA2587284A1 (en) 2006-07-13
WO2006074409A1 (en) 2006-07-13
US7129215B2 (en) 2006-10-31
MX2007008255A (es) 2007-09-11
NZ555362A (en) 2009-05-31
SI1833978T1 (sl) 2009-04-30
BRPI0606396A2 (pt) 2009-06-23
JP4903717B2 (ja) 2012-03-28
CA2587310A1 (en) 2006-07-13
TW200635949A (en) 2006-10-16
PT1833842E (pt) 2008-12-11
IL182836A0 (en) 2007-08-19
TWI317739B (en) 2009-12-01
WO2006074249A1 (en) 2006-07-13
SI1833842T1 (sl) 2009-04-30
ES2314891T3 (es) 2009-03-16
IL182836A (en) 2010-11-30
AU2006204022B2 (en) 2011-01-20
EP1833842B1 (en) 2008-10-08
AU2006204022A1 (en) 2006-07-13
EP1833978B1 (en) 2008-10-08
TW200635948A (en) 2006-10-16
KR20070104391A (ko) 2007-10-25
US20060148719A1 (en) 2006-07-06
MX2007008254A (es) 2007-09-11
US7192918B2 (en) 2007-03-20
EP1833842A1 (en) 2007-09-19
BRPI0606520A2 (pt) 2009-06-30
NZ555361A (en) 2009-05-31
US20060160749A1 (en) 2006-07-20
DK1833978T3 (da) 2009-02-09
DK1833842T3 (da) 2009-02-09
JP2008526880A (ja) 2008-07-24
HK1106796A1 (en) 2008-03-20
PT1833978E (pt) 2008-12-02
AR051890A1 (es) 2007-02-14
IL183107A0 (en) 2007-09-20
ES2314890T3 (es) 2009-03-16
HK1106778A1 (en) 2008-03-20
JP4903716B2 (ja) 2012-03-28
DE602006003063D1 (de) 2008-11-20
PL1833842T3 (pl) 2009-04-30
DE602006003064D1 (en) 2008-11-20
ZA200704487B (en) 2008-09-25
WO2006074409A9 (en) 2006-12-14
CN101090977A (zh) 2007-12-19
ZA200704488B (en) 2008-09-25
CN101090977B (zh) 2013-04-10
CN101080418A (zh) 2007-11-28
AU2006203901B2 (en) 2011-06-02
EP1833978A1 (en) 2007-09-19
AU2006203901A1 (en) 2006-07-13
EA200701398A1 (ru) 2007-12-28
EA200701399A1 (ru) 2008-02-28
HRP20090128T3 (hr) 2009-04-30
AR051889A1 (es) 2007-02-14
IL183107A (en) 2010-11-30
TWI317738B (en) 2009-12-01
JP2008526859A (ja) 2008-07-24
CA2587310C (en) 2013-11-12
CA2587284C (en) 2014-03-25
PL1833978T3 (pl) 2009-04-30
ATE410520T1 (de) 2008-10-15
KR20070091611A (ko) 2007-09-11
HRP20090134T3 (hr) 2009-04-30

Similar Documents

Publication Publication Date Title
KR101244609B1 (ko) 트리펩티드 및 테트라펩티드 티오에테르
KR102362277B1 (ko) 면역조절제로서 1,2,4-옥사디아졸 유도체
JP2018016629A (ja) 固形腫瘍を治療するためのｆａｐ活性化プロテアソーム阻害剤
US11312748B2 (en) Derivatives of dolaproine-dolaisoleucine peptides
CN109796519A (zh) 一类甾体化合物及其应用
HK1106796B (en) Tripeptide and tetrapeptide thioethers
HK1106778B (en) Tripeptide and tetrapeptide sulfones
Pleasanton et al. Aurrecoechea et al.(43) Pub. Date: Jul. 20, 2006

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20160312

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20160312